Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Inventory (2022 - 2025)

Historic Inventory for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $3.3 million.

  • TriSalus Life Sciences' Inventory fell 1807.95% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 1807.95%. This contributed to the annual value of $4.0 million for FY2024, which is 5905.7% up from last year.
  • Latest data reveals that TriSalus Life Sciences reported Inventory of $3.3 million as of Q3 2025, which was down 1807.95% from $3.8 million recorded in Q2 2025.
  • TriSalus Life Sciences' 5-year Inventory high stood at $4.2 million for Q1 2025, and its period low was $1.5 million during Q4 2022.
  • Over the past 4 years, TriSalus Life Sciences' median Inventory value was $3.4 million (recorded in 2024), while the average stood at $3.1 million.
  • As far as peak fluctuations go, TriSalus Life Sciences' Inventory soared by 14548.8% in 2024, and later tumbled by 1807.95% in 2025.
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Inventory stood at $1.5 million in 2022, then soared by 73.01% to $2.5 million in 2023, then skyrocketed by 59.06% to $4.0 million in 2024, then decreased by 19.07% to $3.3 million in 2025.
  • Its Inventory stands at $3.3 million for Q3 2025, versus $3.8 million for Q2 2025 and $4.2 million for Q1 2025.